Wolverine Trading
CARM

Wolverine Trading’s Carisma Therapeutics CARM Stock Holding History

Wolverine Trading’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-838
Closed -$11.4K – 4645
2022
Q2 		$13K Buy
+838
New +$9.59K ﹤0.01% 4292
2021
Q4 		– Sell
-1,058
Closed -$16K – 5955
2021
Q3 		$16K Buy
+1,058
New +$50.8K ﹤0.01% 6159

Other funds holding CARM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wolverine Trading's CARM Position: Q3 2022 in Review

Wolverine Trading sold out of Carisma Therapeutics (CARM) in Q3 2022, closing a stake of 838 shares — an estimated $11.4K sold.

Wolverine Trading first reported a position in CARM in Q3 2021 and held it in 2 quarters. The position peaked at $16K in Q3 2021. 68 funds tracked by Wall St. Rank hold CARM as of Q3 2022.

  • Wolverine Trading reported no remaining Carisma Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Wolverine Trading sold 838 Carisma Therapeutics shares in Q3 2022, an estimated $11.4K.
  • Wolverine Trading first reported a position in Carisma Therapeutics in Q3 2021 and held it in 2 quarters.
  • Wolverine Trading's Carisma Therapeutics position peaked at $16K in Q3 2021.
  • 68 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q3 2022.

Based on Wolverine Trading's 13F filing for Q3 2022, filed 14 Nov 2022.